Abstract
Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have